Laurie Zoloth of Northwestern University and Jan Helge Solbakk of the University of Oslo have backed Leigh Turner and sent a letter to the FDA reinforcing his concerns about Celltex. Solbakk is the current chair of the Ethics and Public Policy Committee of the International Society for Stem Cell Research; Zoloth is a former chair of the committee. Their letter can be found here. An excerpt: “We are also concerned about the climate that has come to surround this request, for we understand that scholars who have raised questions about CellTex in the last few weeks have received threats of litigation from the company`s legal counsel. We wish to affirm that freely raising our most critical and rigorous questions seems to be precisely the point of our fields of bioethics and moral philosophy. Efforts to silence debate or to limit inquiry raises serious problems in a field that seeks honest and transparent processes.”
Read the background here.